HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases.

AbstractOBJECTIVE:
The association between vasculitis and large granular lymphocyte (LGL) leukemia has rarely been reported or investigated. Thus, we assessed the clinical and biological phenotypes of LGL leukemia associated with vasculitis.
RESULTS:
We studied a series of 11 patients displaying LGL leukemia associated with vasculitis (LAV). The mean age at diagnosis of LGL leukemia was 60.3 years; there were nine women and two men. The mean follow-up period was 45 months. The main LGL lineage was T-LGL (10 patients), and only one NK-LGL was identified. Clinical and biological features of T-LGL leukemia were compared with those from the 2009 French T-LGL registry. We did not find any relevant differences except that patients with LAV were predominantly female (p < 0.05). The most frequently observed vasculitis was cryoglobulinemia (n = 5). Three patients presented with cutaneous leukocytoclastic angiitis, two patients had ANCA-negative microscopic polyangiitis, and one patient had giant cell arteritis. The main clinical features involved the skin, e.g., purpura (91%), arthralgia (37%), peripheral neuritis (27%), and renal glomerulonephritis (18%). The most frequent histologic finding was leucocytoclastic vasculitis (54%). The rate of complete remission was high; i.e., 80%. A minority of patients had a vasculitis relapse (27%). Three patients (27%) died; one death was related to LGL leukemia (acute infection) and the two other deaths were related to vasculitis (both with heart failure).
CONCLUSION:
We conclude that vasculitis is overrepresented in the population of LGL patients, LAV predominantly affects women, vasculitis preferentially affects the small vessels, and LAV has high rate of complete response.
AuthorsAlexandra Audemard, Thierry Lamy, Benoît Bareau, Flore Sicre, Felipe Suarez, Florence Truquet, Véronique Salaun, Magaret Macro, Laurence Verneuil, Thierry Lobbedez, Cindy Castrale, Jonathan Boutemy, Stéphane Cheze, Loïk Geffray, Nicolas Schleinitz, Jérôme Rey, Estibaliz Lazaro, Loïc Guillevin, Boris Bienvenu
JournalSeminars in arthritis and rheumatism (Semin Arthritis Rheum) Vol. 43 Issue 3 Pg. 362-6 (Dec 2013) ISSN: 1532-866X [Electronic] United States
PMID24326032 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Glucocorticoids
  • Immunosuppressive Agents
Topics
  • Adult
  • Aged
  • Female
  • Glucocorticoids (therapeutic use)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Leukemia, Large Granular Lymphocytic (complications, drug therapy)
  • Male
  • Middle Aged
  • Treatment Outcome
  • Vasculitis (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: